Get the Stockscreener App
12.40
1.90%
-0.24
Pre-market:
13.49
1.09
+8.79%
Briacell Therapeutics Corp stock is traded at $12.40, with a volume of 61,423.
It is down -1.90% in the last 24 hours and up +60.00% over the past month.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
See More
Previous Close:
$12.64
Open:
$12.68
24h Volume:
61,423
Relative Volume:
0.08
Market Cap:
$23.36M
Revenue:
-
Net Income/Loss:
$-16.60M
P/E Ratio:
-13.93
EPS:
-0.89
Net Cash Flow:
$-23.48M
1W Performance:
-5.20%
1M Performance:
+60.00%
6M Performance:
+209.23%
1Y Performance:
-18.15%
1-Day Range:
$12.16
$12.97
1-Week Range:
$12.16
$13.60
52-Week Range:
$0.61
$19.05
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics Corp
Sector
Industry
Phone
(604) 921-1810
Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
12.40 | 22.18M | 0 | -16.60M | -23.48M | -0.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-22 | Initiated | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Stock (BCTX) Latest News
Will BriaCell Therapeutics Corp. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - newser.com
Applying Wyckoff theory to BriaCell Therapeutics Corp. Equity Warrant stockJuly 2025 Setups & Verified Momentum Stock Watchlist - newser.com
What institutional flow reveals about BriaCell Therapeutics Corp. Equity WarrantMarket Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
BriaCell Therapeutics Corp Stock Analysis and ForecastBreakout Stock Watch & Superior Capital Appreciation - earlytimes.in
What data driven models say about BriaCell Therapeutics Corp.’s future2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
Combining machine learning predictions for BriaCell Therapeutics Corp. Equity WarrantJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
BriaCell Therapeutics : Investor Presentation (20251010 Investor Presentation) - MarketScreener
BriaCell Therapeutics Corp. Equity Warrant stock prediction for this weekStock Surge & Safe Entry Momentum Tips - newser.com
Risk adjusted return profile for BriaCell Therapeutics Corp. Equity Warrant analyzedJuly 2025 Technicals & Daily Stock Momentum Reports - newser.com
Why retail investors favor BriaCell Therapeutics Corp. Equity Warrant stockWeekly Trend Summary & Fast Moving Trade Plans - newser.com
How strong is BriaCell Therapeutics Corp. Equity Warrant stock balance sheetJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
What earnings margins imply for BriaCell Therapeutics Corp. (8BT0) stockRate Hike & Technical Confirmation Trade Alerts - newser.com
A activityJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com
Will breakout in BriaCell Therapeutics Corp. Equity Warrant lead to full recoveryJuly 2025 Fed Impact & Fast Gain Swing Trade Alerts - newser.com
Will BriaCell Therapeutics Corp. continue its uptrendIPO Watch & Risk Managed Investment Strategies - newser.com
Is BriaCell Therapeutics Corp. trending in predictive chart modelsFed Meeting & Daily Growth Stock Tips - newser.com
How to monitor BriaCell Therapeutics Corp. Equity Warrant with trend dashboardsEarnings Risk Summary & Real-Time Chart Breakout Alerts - newser.com
What candlestick patterns are forming on BriaCell Therapeutics Corp. Equity WarrantCPI Data & Daily Profit Maximizing Tips - newser.com
What analysts say about BriaCell Therapeutics Corp stockSupport Level Holds & Access Advanced Stock Screening Tools - earlytimes.in
Using Bollinger Bands to evaluate BriaCell Therapeutics Corp. Equity WarrantWeekly Trend Summary & Risk Managed Investment Strategies - newser.com
Is BriaCell Therapeutics Corp. meeting your algorithmic filter criteriaBuy Signal & Expert Curated Trade Ideas - newser.com
Published on: 2025-10-05 05:44:06 - newser.com
Using flow based indicators on BriaCell Therapeutics Corp. Equity WarrantQuarterly Trade Review & Capital Efficient Trade Techniques - newser.com
(BCT) Advanced Trading Insights (BCT:CA) - news.stocktradersdaily.com
Published on: 2025-10-05 03:55:06 - newser.com
How hedge fund analytics apply to BriaCell Therapeutics Corp. stockEarnings Overview Summary & Weekly High Return Opportunities - newser.com
Risk vs reward if holding onto BriaCell Therapeutics Corp. Equity WarrantJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting - GlobeNewswire
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell to Present Innovative Cancer Vaccine Data at SITC 2025 - TipRanks
Why BriaCell Therapeutics Corp. stock is a value investor pickQuarterly Profit Report & AI Enhanced Market Trend Forecasts - newser.com
SITC 40th Anniversary: Bria-OTS+ Preclinical Poster — BriaCell to Present Nov 7, 2025 - Stock Titan
Visual trend scoring systems applied to BriaCell Therapeutics Corp.2025 Sector Review & Safe Entry Zone Tips - newser.com
Briacell Therapeutics Corp Stock (BCTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):